HEAL Funding Opportunities

HEAL Funding Opportunities

The NIH HEAL Initiative invests in research to accelerate scientific solutions to address the national opioid overdose crisis and improve pain management. Below, you can explore open Funding Opportunities and Forecasts that support innovative research across the HEAL portfolio.
 

Opportunity or Forecast ID

Title

Activity Code

Research Area

Closing Date

PAR-25-154

HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)

R03

Preclinical

7/16/2026

PAR-25-051

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

UG3/UH3

Preclinical

8/18/2026

RFA-AT-25-003

HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)

R15

Preclinical

11/23/2026

RFA-NS-25-023

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

R61/R33

Preclinical

1/15/2027

PA-24-185

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)

K23

Workforce Development

5/7/2027

PA-24-194

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

K99/R00

Workforce Development

5/7/2027

PA-24-176

Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

K01

Workforce Development

5/7/2027

PAR-25-100

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

R34

Implementation & Health Services, Recovery Services

5/8/2027

PAS-25-236

D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)

R03

Data Dissemination & Secondary Analysis

9/7/2027

RFA-DA-26-055

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

R01

Data Dissemination & Secondary Analysis

12/3/2027

RFA-DA-26-056

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

R21

Data Dissemination & Secondary Analysis

12/3/2027

PA-25-302

NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

R03

Preclinical, Therapeutics Development, Prevention, Recovery Services, Implementation & Health Services, Life Course & Population, Data Dissemination & Secondary Analysis

1/7/2028

PA-25-304

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

R21

Preclinical, Therapeutics Development, Prevention, Recovery Services, Implementation & Health Services, Life Course & Population, Data Dissemination & Secondary Analysis

1/7/2028

PA-25-301

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

R01

Preclinical, Therapeutics Development, Prevention, Recovery Services, Implementation & Health Services, Life Course & Population, Data Dissemination & Secondary Analysis

1/7/2028

PAR-25-446

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

UG3/UH3

Therapeutics Development

8/21/2028

PA-26-001

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

UG3/UH3

Preclinical, Therapeutics Development, Prevention, Recovery Services, Implementation & Health Services, Life Course & Population, Data Dissemination & Secondary Analysis

11/30/2028

FOR-NS-25-002

Forecast for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional),

UG3/UH3

Therapeutics Development

FORECASTED

RFA-NS-25-031

HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

UG3/UH3

Therapeutics Development, Implementation & Health Services

FORECASTED

RFA-TR-26-002

Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Network (ERN) (Clinical Trial Not Allowed)

ERN

Therapeutics Development, Implementation & Health Services

FORECASTED

FOR-DA-26-001

HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

R61/R33

Prevention, Recovery Services, Implementation & Health Services

FORECASTED

FOR-DA-27-001

HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems

IMPOWR

Implementation & Health Services

FORECASTED

RFA-DA-27-006

HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center

IMPOWR/BEACON

Implementation & Health Services

FORECASTED

FOR-DA-26-002

Limited Competition for the HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study (Collaborative U01- Clinical Trial Not Allowed)

U01

Life Course & Population

FORECASTED

FOR-DA-26-003

Limited Competition for the HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study – Coordinating Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed)

U24

Life Course & Population

FORECASTED

This page last reviewed on